Efficacy of Preerythrocytic and Blood-Stage Malaria Vaccines Can Be Assessed in Small Sporozoite Challenge Trials in Human Volunteers

被引:37
作者
Roestenberg, Meta [1 ]
de Vlas, Sake J. [2 ]
Nieman, An-Emmie [3 ]
Sauerwein, Robert W. [1 ]
Hermsen, Cornelus C. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands
[2] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands
关键词
POLYMERASE-CHAIN-REACTION; PLASMODIUM-FALCIPARUM;
D O I
10.1093/infdis/jis355
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The development of a vaccine against malaria has public health priority. In a controlled setting, preliminary data on the efficacy of Plasmodium falciparum vaccine candidates can be obtained by exposing immunized human volunteers to the bites of laboratory-reared P. falciparum-infected mosquitoes. Using empirical data, we show that these trials, with small numbers of volunteers, are sufficiently powered to detect protective biological effects induced by preerythrocytic and/or blood-stage candidate vaccines if parasitemia is measured daily by quantitative polymerase chain reaction. Sporozoite challenge trials are thus a powerful tool for early selection of candidates that warrant efficacy of trials in the field.
引用
收藏
页码:319 / 323
页数:5
相关论文
共 15 条
[1]   First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children [J].
Agnandji, Selidji Todagbe ;
Lell, Bertrand ;
Soulanoudjingar, Solange Solmeheim ;
Fernandes, Jose Francisco ;
Abossolo, Beatrice Peggy ;
Conzelmann, Cornelia ;
Methogo, Barbara Gaelle Nfono Ondo ;
Doucka, Yannick ;
Flamen, Arnaud ;
Mordmueller, Benjamin ;
Issifou, Saadou ;
Kremsner, Peter Gottfried ;
Sacarlal, Jahit ;
Aide, Pedro ;
Lanaspa, Miguel ;
Aponte, John J. ;
Nhamuave, Arlindo ;
Quelhas, Diana ;
Bassat, Quique ;
Mandjate, Sofia ;
Macete, Eusebio ;
Alonso, Pedro ;
Abdulla, Salim ;
Salim, Nahya ;
Juma, Omar ;
Shomari, Mwanajaa ;
Shubis, Kafuruki ;
Machera, Francisca ;
Hamad, Ali Said ;
Minja, Rose ;
Mpina, Maxmillian ;
Mtoro, Ali ;
Sykes, Alma ;
Ahmed, Saumu ;
Urassa, Alwisa Martin ;
Ali, Ali Mohammed ;
Mwangoka, Grace ;
Tanner, Marcel ;
Tinto, Halidou ;
D'Alessandro, Umberto ;
Sorgho, Hermann ;
Valea, Innocent ;
Tahita, Marc Christian ;
Kabore, William ;
Ouedraogo, Sayouba ;
Sandrine, Yara ;
Guiguemde, Robert Tinga ;
Ouedraogo, Jean Bosco ;
Hamel, Mary J. ;
Kariuki, Simon .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (20) :1863-1875
[2]  
[Anonymous], MAL VACC TECHN ROADM
[3]   Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites [J].
Bejon, P ;
Andrews, L ;
Andersen, RF ;
Dunachie, S ;
Webster, D ;
Walther, M ;
Gilbert, SC ;
Peto, T ;
Hill, AVS .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (04) :619-626
[4]   Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+T cells but does not protect against experimental Plasmodium falciparum infection [J].
Cummings, James F. ;
Spring, Michele D. ;
Schwenk, Robert J. ;
Ockenhouse, Christian F. ;
Kester, Kent E. ;
Polhemus, Mark E. ;
Walsh, Douglas S. ;
Yoon, In-Kyu ;
Prosperi, Christine ;
Juompan, Laure Y. ;
Lanar, David E. ;
Krzych, Urszula ;
Hall, B. Ted ;
Ware, Lisa A. ;
Stewart, V. Ann ;
Williams, Jack ;
Dowler, Megan ;
Nielsen, Robin K. ;
Hillier, Collette J. ;
Giersing, Birgitte K. ;
Dubovsky, Filip ;
Malkin, Elissa ;
Tucker, Kathryn ;
Dubois, Marie-Claude ;
Cohen, Joe D. ;
Ballou, W. Ripley ;
Heppner, D. Gray, Jr. .
VACCINE, 2010, 28 (31) :5135-5144
[5]   A DNA prime-modified vaccinia virus Ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge [J].
Dunachie, S. J. ;
Walther, M. ;
Epstein, J. E. ;
Keating, S. . ;
Berthoud, T. ;
Andrews, L. ;
Andersen, R. F. ;
Bejon, P. ;
Goonetilleke, N. ;
Poulton, I. ;
Webster, D. P. ;
Butcher, G. ;
Watkins, K. ;
Sinden, R. E. ;
Levine, G. L. ;
Richie, T. L. ;
Schneider, J. ;
Kaslow, D. ;
Gilbert, S. C. ;
Carucci, D. J. ;
Hill, A. V. S. .
INFECTION AND IMMUNITY, 2006, 74 (10) :5933-5942
[6]   Randomized double-blind controlled Phase I/IIa trial to assess the efficacy of malaria vaccine PfCS102 to protect against challenge with P-falciparum [J].
Genton, Blaise ;
D'Acremont, Valerie ;
Lurati-Ruiz, Floriana ;
Verhage, Daniele ;
Audran, Regine ;
Hermsen, Cornelus ;
Wolters, Liselotte ;
Reymond, Christophe ;
Spertini, Francois ;
Sauervvein, Robert .
VACCINE, 2010, 28 (40) :6573-6580
[7]   Testing vaccines in human experimental malaria: Statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction [J].
Hermsen, CC ;
De Vlas, SJ ;
Van Gemert, GJA ;
Telgt, DSC ;
Verhage, DF ;
Sauerwein, RW .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2004, 71 (02) :196-201
[8]   Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR [J].
Hermsen, CC ;
Telgt, DSC ;
Linders, EHP ;
van de Locht, LATF ;
Eling, WMC ;
Mensink, EJBM ;
Sauerwein, RW .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2001, 118 (02) :247-251
[9]   Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum [J].
Pombo, DJ ;
Lawrence, G ;
Hirunpetcharat, C ;
Rzepczyk, C ;
Bryden, M ;
Cloonan, N ;
Anderson, K ;
Mahakunkijcharoen, Y ;
Martin, LB ;
Wilson, D ;
Elliott, S ;
Elliott, S ;
Eisen, DP ;
Weinberg, JB ;
Saul, A ;
Good, MF .
LANCET, 2002, 360 (9333) :610-617
[10]   Blood-stage challenge for malaria vaccine efficacy trials: A pilot study with discussion of safety and potential value [J].
Sanderson, Frances ;
Andrews, Laura ;
Douglas, Alexander D. ;
Hunt-Cooke, Angela ;
Bejon, Philip ;
Hill, Adrian V. S. .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 78 (06) :878-883